219 related articles for article (PubMed ID: 2531219)
1. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.
Russell CD; Taylor A; Eshima D
J Nucl Med; 1989 Dec; 30(12):1955-9. PubMed ID: 2531219
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers.
Bormans GM; Cleynhen BJ; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1992; 19(4):271-7. PubMed ID: 1534544
[TBL] [Abstract][Full Text] [Related]
3. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
5. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples.
Gordon I; Anderson PJ; Orton M; Evans K
J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838
[TBL] [Abstract][Full Text] [Related]
6. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
8. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
10. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
[TBL] [Abstract][Full Text] [Related]
11. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of renal function with technetium-99m MAG3.
Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
[TBL] [Abstract][Full Text] [Related]
15. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
16. The utility of 99mTc-mercaptoacetyltriglycine in captopril renography.
Taylor A; Martin LG
Am J Hypertens; 1991 Dec; 4(12 Pt 2):731S-736S. PubMed ID: 1837994
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
18. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A; Corrigan P; Eshima D; Folks R
J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
[TBL] [Abstract][Full Text] [Related]
20. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]